Original Research
Published on 25 Nov 2021
Periplocymarin Induced Colorectal Cancer Cells Apoptosis Via Impairing PI3K/AKT Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.753598
- 3,036 views
- 18 citations
Type at least 3 characters
1,009 articles
Articles
Review
Published on 24 Nov 2021
Navigating Multi-Scale Cancer Systems Biology Towards Model-Driven Clinical Oncology and Its Applications in Personalized Therapeutics
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.712505
- 5,428 views
- 10 citations
Original Research
Published on 24 Nov 2021
Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.793006
- 2,587 views
- 11 citations
Original Research
Published on 22 Nov 2021
Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.762288
- 5,032 views
- 7 citations
Mini Review
Published on 18 Nov 2021
Trabectedin-Related Heart Failure: Case Report and a Systematic Review of the Literature
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.694620
- 3,739 views
- 3 citations
Systematic Review
Published on 18 Nov 2021
A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.690515
- 4,827 views
- 8 citations
Case Report
Published on 17 Nov 2021
Stevens-Johnson Syndrome Caused by Enzalutamide: A Case Report and Literature Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.736975
- 3,558 views
- 6 citations
Case Report
Published on 11 Nov 2021
Successful Treatment of an Elderly Patient With Combined Small Cell Lung Cancer Receiving Anlotinib: A Case Report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.775201
- 1,957 views
- 3 citations
Original Research
Published on 09 Nov 2021
Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.743765
- 2,239 views
- 2 citations
Systematic Review
Published on 09 Nov 2021
Antitumor Effects of Evodiamine in Mice Model Experiments: A Systematic Review and Meta-Analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.774201
- 2,561 views
- 2 citations
Original Research
Published on 09 Nov 2021
Proteome Analysis of Camellia nitidissima Chi Revealed Its Role in Colon Cancer Through the Apoptosis and Ferroptosis Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.727130
- 5,132 views
- 24 citations
Original Research
Published on 08 Nov 2021
LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.782065
- 5,364 views
- 14 citations
Original Research
Published on 04 Nov 2021
Perifosine, a Bioavailable Alkylphospholipid Akt Inhibitor, Exhibits Antitumor Activity in Murine Models of Cancer Brain Metastasis Through Favorable Tumor Exposure
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.754365
- 3,212 views
- 4 citations
Original Research
Published on 02 Nov 2021
Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.720343
- 3,046 views
- 17 citations
Original Research
Published on 02 Nov 2021
Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.768879
- 6,313 views
- 20 citations
Editorial
Published on 29 Oct 2021
Editorial: Enhancing Drug Delivery and Tumor Penetration
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.775001
- 1,616 views